Symbol="HARP"
AssetType="Common Stock"
Name="Harpoon Therapeutics Inc"
Description="Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, is involved in the development of a new class of T-cell activators that harness the power of the body's immune system to treat patients with cancer and other diseases in the United States. . The company is headquartered in South San Francisco, California."
CIK="1708493"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="131 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="29700700"
EBITDA="-56362000"
PERatio="None"
PEGRatio="None"
BookValue="0.019"
DividendPerShare="0"
DividendYield="0"
EPS="-1.63"
RevenuePerShareTTM="1.012"
ProfitMargin="-1.698"
OperatingMarginTTM="-1.699"
ReturnOnAssetsTTM="-0.344"
ReturnOnEquityTTM="-2.791"
RevenueTTM="34592000"
GrossProfitTTM="-49478000"
DilutedEPSTTM="-1.63"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.453"
AnalystTargetPrice="5.33"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="0.746"
PriceToBookRatio="1.493"
EVToRevenue="0.587"
EVToEBITDA="0.433"
Beta="1.548"
num_52WeekHigh="2.19"
num_52WeekLow="0.544"
num_50DayMovingAverage="0.754"
num_200DayMovingAverage="0.776"
SharesOutstanding="37595800"
DividendDate="None"
ExDividendDate="None"
symbol="HARP"
open="0.85"
high="0.93"
low="0.81"
price="0.83"
volume="257742.00"
latest_trading_day="2023-08-10"
previous_close="0.81"
change="0.02"
change_percent="2.8925%"
aroon_positive_momentum_days="64"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="64"
Volume_recent_avg="205067"
Change_recent_avg="0.01"
Delta_recent_avg="0.06"
Variance_recent_avg="0.03"
Change_ratio_recent_avg="-0.61"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="64"
Aroon_momentum_negative="36"
image_negative_thumbnail_id_1="1164"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0198.jpeg"
image_negative_thumbnail_id_2="509"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0096.jpeg"
image_neutral_thumbnail_id_1="564"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_neutral_thumbnail_id_2="572"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0027.jpeg"
image_positive_thumbnail_id_1="1007"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0169.jpeg"
image_positive_thumbnail_id_2="1014"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0176.jpeg"
image_professor_thumbnail_id_1="1172"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0006.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
